Clinical Trial Update: RESCUE and REVERSE Long-term Follow-up [Phase 3]

View source ↗

Summary

Long-term follow-up results from GenSight Biologics' Phase 3 RESCUE and REVERSE trials in Leber hereditary optic neuropathy have been posted, reporting extended…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Hereditary Optic Neuropathy

Drugs mentioned

• lenadogene nolparvovec (lenadogene nolparvovec)

Snippet

Sponsor: GenSight Biologics | Conditions: Leber Hereditary Optic Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2024-01-25